Global Unilateral Vocal Cord Paralysis Market Set For Big Growth - Foresight By 2023

 Market Highlights

Unilateral vocal cord paralysis is a speech disorder caused by neurological complications, it is the condition where one vocal cord does not move or shows less movement. It can cause a breathy voice, swallowing disability, weak cough and shortness of breath. The increasing cases of speech disorders, rising healthcare expenditure, and technological advancement are the major factors driving the growth of the global unilateral vocal cord paralysis market. Moreover, the growing prevalence of head and neck cancers is likely to boost the growth of the market. According to the American Society of Clinical Oncology (ASCO), It was estimated that 64,690 people will suffer from head and neck cancers and 13,740 deaths will occur due to head and neck cancer in the year 2017.

The increasing surgical treatment rates and scarcity of experts are likely to hinder the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6356 

Regional Analysis

The market in the Americas is expected to dominate the global unilateral vocal cord paralysis market during the forecast period. The presence of a well-established healthcare sector, growing prevalence of voice disorders, and increasing expenditure for the healthcare sector are driving the growth of the market in this region. The European market is expected to be the second-largest due to the support provided by government bodies for the healthcare sector, increasing research and development activities, and improvement in reimbursement policies. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development, increasing healthcare expenditure, and developing healthcare sector and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global unilateral vocal cord paralysis market. The market growth in this region can be attributed to the increasing investment in the healthcare sector in developing countries.

Segmentation

The global unilateral vocal cord paralysis market has been segmented on the basis of treatment, diagnosis, and end-user.

On the basis of treatment, the market has been classified into medical treatment and surgical treatment. The medical treatment segment has been further divided into medication and voice therapy. The voice therapy segment has been further divided into direct voice therapy, voice hygiene treatment, and voice test environment treatment. Direct voice therapy subsegment has been classified into flow phonation and resonant voice and respiratory support technique. Surgical treatment segment has been divided into endoscopic injection and permanent treatment. Permanent treatment segment has been further divided into vocal fold injection and laryngeal framework surgery.

The diagnosis segment has been divided into laryngoscopy and laryngeal electromyography (LEMG) and blood test & scans. Blood test and scans segment has been further classified into X-rays, CT scans, MRI scans.

The market, by end-user, has been segmented into hospitals, clinics, diagnostic centers and others.

Key Players

Some of the key players in the global unilateral vocal cord paralysis market are Stryker Corporation, Hoya Corporation, Teleflex Incorporated, Therapy Solutions Inc., Smiths Group plc, Smart Speech Therapy LLC, Olympus Corporation of the Americas, Medtronic Plc., KARL STORZ SE & Co. KG, RENÚ, Cytophil, Inc., Acclarent, Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/unilateral-vocal-cord-paralysis-market-6356 

Next-Generation Sequencing Market 2020 – Leading Manufactures, Regions, Drivers, Analysis And Forecasts Till 2025

 Market Highlights

There are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease, etc. To discover viable treatment for these diseases, researchers are looking to discern how genes work. The next-generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to the field of genomics. The NGS technologies are implemented for several applications, including whole-genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level. The successful application of next-generation sequencing can lead to predicting genes, protein-coding regions, and pathways.

Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next-generation sequencing market which is estimated to reach at a CAGR of 18.05% over the forecast period and USD 20,347.45 Million by 2025.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6354 

Segmentation

The Next Generation Sequencing Market has been classified by Technology, Service and Product, Application, and End-User.

By technology, the next-generation sequencing market has been segmented as whole-genome sequencing, methyl sequencing, whole-exome sequencing, targeted resequencing, CHIP sequencing, RNA sequencing, and de novo sequencing.

By service & product, the next-generation sequencing market has been segmented as consumables, sample preparation, sequencing services, and platforms and services for platforms.

By application, the NGS market has been segmented as genetic screening, drug discovery, diagnostics, agriculture and animal research, and others.

End-users segmentation of the next generation sequencing market includes academic institutes and research centers, pharmaceutical and biotechnology companies, hospitals and clinics, and other end-users.

Regional Analysis

Owing to the rising number of funds being granted for research into genomics and initiatives adopted by the government to rein in cases of genetically occurring diseases and demand to improve the healthcare sector is estimated to augment the growth of the next-generation sequencing market in North America. Increased competition among market players as well as acquisitions and mergers are expected to drive the growth of the market in the region.

The next-generation sequencing market in Europe is expected to hold the second-largest revenue share due to the presence of some of the leading next-generation sequencing technology companies and an educated population inclined on the advancement of next-generation sequencing technology. Though diverse regulations and a fragmented NGS market might restrain the growth of the market in the region, favorable funding scenario and immense support for scientific research would augment the next-generation sequencing market in the region.

The next-generation sequencing market share in Asia-Pacific is projected to witness expansion over the coming years due to growing demand for advanced technology and access to enhanced treatment facilities, better adoption of advanced genomics, an increase in disposable income, and rising investments in diverse treatment options by pharmaceutical companies.

Due to lack of technical knowledge, an underdeveloped healthcare sector, and poor medical facilities the next-generation sequencing market in the Middle East and Africa is expected to garner the smallest share.

Competitive Landscape

Some of the Key Players in the Global Next-Generation Sequencing Market Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI, PerkinElmer, Agilent Technologies, QIAGEN N. V., Macrogen Inc., Oxford Nanopore Technologies, Ltd., and Eurofins Scientific.

Industry News

Recently, Thermo Fisher Scientific launched its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing platform that delivers results economically in a single day. This turnkey solution is designed to enable local hospitals to adopt NGS testing.

According to a study published in Clinical Lung Cancer local hospitals are severely challenged when it comes to providing NGS-based genomic testing at present even though hospitals are where most patients are treated. Due to limitations to NGS adoption, such as product complexity and cost, the vast majority of local molecular laboratories rely on single-gene tests. Some laboratories even have to outsource testing for more comprehensive NGS analysis as single-gene tests fail to provide a complete genomic profile of a tumor. Ion Torrent Genexus System is expected to solve many of the problems faced by hospitals when it comes to gene testing thus increasing growth scope for next-generation sequencing.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354

The Animal Genetics Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 Animal Genetics Market Overview

According to the Market Research Future (MRFR) analysis, the global animal genetics market is estimated to register a CAGR of 8.4% from 2018 to 2023 (forecast period). The report offers an in-depth overview of the industry, including production, suppliers, quality, consumption, growth rate, profit margins, services, imports and exports, and technology advancements.

Animal genetics is a field of genetics that is dedicated to the study of genetic variability and inheritance, especially for domestic and wild animals. For commercial purposes, animal genetics is used for DNA typing, genetic disease testing, and genetic trait testing. This methodology uses a hybrid population, ontogenetic, and cytological studies to determine genetic hybridizations. For example, genetically modified cows may be able to produce more milk and may be less vulnerable to common cattle diseases, such as clostridial disease, bovine respiratory disease complex, etc., thereby increasing the overall income of cattle farmers. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7004

Animal Genetics Market Dynamics  

The significant factor responsible for influencing this market is the increase in the consumption of animal-derived protein, the growth of the global population, and rapid urbanization. The increasing focus on the identification of superior breeds has contributed to the growth of the market for toxicology testing. 

However, factors such as the substantial cost of animal testing, the stringent regulatory framework for genetic engineering, and the lack of qualified professionals are expected to inhibit the market growth during the forecast period. 

Animal Genetics Market Segmentation

The global market for animal genetics market is segmented based on animal genetic products, services, and end-users. 

Based on animal genetic products, the global market for animal genetics market is segmented into genetic materials and live animals. The live animals are further divided into poultry, bovine, porcine, canine, and others. The genetic materials are sub-segmented into semen and embryo. 

Based on services, the global market for animal genetics is segmented into genetic disease tests, DNA typing, gene trait tests, and others. 

Based on end-user, the global market for animal genetics is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others. 

Animal Genetics Market Regional Analysis

Regionally, the global animal genetics market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global market for animal genetics in 2017. This was due to the growth in the North American region, primarily due to factors such as growing demand for animal products such as pork and mutton. Moreover, rapid urbanization is likely to spur market demand for live animals in the coming years. Growing adoption of artificial insemination, particularly in cattle, sheep, pigs, and goats, is fueling the market growth.

Europe was the second-largest region for the global animal genetics market. Due to rising awareness of animal health, the increase in the number of numerous animal genetic diseases, and the increased prevalence of the zoonotic disease is projected to provide this market with profitable growth opportunities.

The Asia Pacific was expected to be the fastest-growing area on the global market for animal genetics in 2017. Factors due to the increasing population of livestock and the development of DNA typing and genetic testing methods further increase the demand for genetic trait tests and various diagnostic tests. 

Animal Genetics Market Key players

Some of the major participants in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), Groupe Grimaud (France), Animal Genetics (US), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), EW Group (Germany), Envigo (US) Hendrix Genetics BV (The Netherland), Alta Genetics (US), vetGen (US), and others.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004 

 

The Bone Growth Stimulator Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2023

 Bone growth stimulators are devices which promote bone health in situations of critical fractures. These devices can use electric current to expedite the healing process. The global bone growth stimulator market report by Market Research Future (MRFR) comprises analysis of latest trends in bone repair, patents of latest devices, and market dynamics for the period of 2018 to 2023 (forecast period). The impact of the COVID-19 pandemic and its effects are also included in the report.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6962

Bone Growth Stimulator Market Scope

Global bone growth stimulator market is expected to grow significantly over the forecast period. The market held a market value of USD 1,213 million in 2017 and is projected to grow at a CAGR of 5.86% over the forecast period. Preference of electric bone stimulation in lieu of surgeries can drive the market growth. According to clinical trials conducted by the Cedars-Sinai Hospital, electric bone growth stimulators can expedite the healing process in ankle fractures. Success of these trials can pave the path for the global bone growth stimulator market.

Bone Growth Stimulator Market Segmentation

The global bone growth stimulator market has been segmented by product, application, and end user.

By product, the market has been segmented into platelet-rich plasma, bone growth stimulation devices, bone morphogenetic proteins, and others. The bone growth stimulation devices segment is further segmented into ultrasonic bone growth stimulators, external bone growth stimulators, and implanted bone growth stimulators. Among the product segment, bone growth stimulation devices are expected to account for the largest share in the global bone growth stimulator market in 2017. This is majorly attributed to the wider acceptance of the devices and better patient compliance.

On the basis of application, the market has been segmented into oral and maxillofacial surgeries, spinal fusion surgeries, delayed union & non-union bone fractures, and others. The spinal fusion surgeries segment is expected to lead in the global bone growth stimulator market in 2017.

On the basis of end users, the market has been segmented into academic and research institutes, hospitals & clinics, home care and others. The hospitals & clinics segment is expected to account for the largest share in the global bone growth stimulator market in 2017. However, growth of home care services in the developed and developing countries has been estimated to drive the segment growth during the forecast period.

Bone Growth Stimulator Market Regional Analysis

Based on the regions, the bone growth stimulator market is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Geographically, the Americas is anticipated to dominate the global bone growth stimulator market owing to the rising prevalence of the orthopedic and spinal ailments such as bone fractures and spinal damage. Development of better therapeutic approaches and advanced treatments has positively affected the regional market growth. Moreover, increasing numbers of spinal fusion procedures, patient preference for orthopedic fixation procedures, high awareness among the population, and high disposable income levels are some of the factors driving the bone growth stimulator market growth.

Europe is expected to hold the second largest market share in the global bone growth stimulator market. The market growth is majorly attributed to the increasing government support for the device manufacturers. Establishment of manufacturing units of medical device companies in this region has brought traction to bone growth stimulators.

Similarly, APAC has observed a rapid growth in the bone growth stimulator market owing to continuous developments in the healthcare sector. Moreover, increase in government funding for healthcare, a rise in R&D expenditure, and growing number of medical device companies in the region is predicted to be highly lucrative for the market in the region.

Lastly, the MEA region is anticipated to show a modest growth rate in the bone growth stimulator market during the forecast period.

Bone Growth Stimulator Market Competition

Depuy Synthes, Harvest Technologies, Orthofix International N.V., Stryker Corporation, Isto Biologics, DJO Finance LLC, Zimmer Biomet Holdings, Inc., Arthrex, Inc., Bioventus LLC, and Medtronic PLC are key players of the global bone growth stimulator market.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/bone-growth-stimulator-market-6962

The Superdisintegrants Systems Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2023

 Market Scenario:

The Global Superdisintegrants Market is anticipted to grow at an optimistic CAGR of 7.9% during the forecast period from 2018 to 2023. Disintegrants are substances which are included in drug formula to allow proper disintegration of the capsule or tablet into easily dissolvable particles. This plays a vital function in the fast absorption of medicine which increases its efficacy. Superdisintegrants are slightly modified disintegrants which offer higher efficiency than their traditional counterparts. Observed to have valued at USD 371 Mn in 2017, the global superdisintegrants market size is poised to appreciate to reach an estimated value of USD 576.2 Mn by the end of 2023.

The pharmaceutical industry is growing at breakneck speed, becoming a significant part of the healthcare sector. This is primarily due to rising populations of both geriatric patients and pediatric patients. Superdisintegrants are helpful for treatment of patients from this demographic as these tablets are easier to swallow. The growth of these demographics is expected to drive market growth. Moreover, generic drugs are in high demand as patents have begun to run out on several popular drug brands, thus opening up the pharmaceutical industry for increased entry of competition and a rise in the manufacturing of generic drugs, thus driving superdisintegrants market demand.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6663

Emerging markets represent significant opportunity as the healthcare sectors in these regions are growing at a swift pace. Moreover, large patient pools are in these countries are expected to increase demand for fast-acting medication. Market players are likely to establish themselves in the region in an effort to leverage the opportunities available in emerging economies.

Players Covered

Prominent market participants that have been profiled in the report include Asahi Kasei Corporation, DFE Pharma, JRS Pharma, Corel Pharma Chem, Ashland Global Holdings Inc., BASF SE, Roquette Freres, DowDuPont Inc., Merck KGaA, and Avantor Performance Materials, LLC

Market Segmentation

MRFR’s analysis of the various segments in the market has been performed on the basis of type, formulation, therapeutic area, and region. Types of superdisintegrants have been segmented into synthetic superdisintegrants, natural disintegrants, and others. Among these, the synthetic superdisintegrants segment has been widely used, making it the most significant market segment. However, the natural superdisintegrants segment is growing at a truly rapid pace due to the growing demand for natural ingredients.

Formulations which include superdisintegrants have been segmented into tablets and capsules. Tablets govern a majority share of the total market, while the capsules segment is expected to grow at the highest CAGR during the review period.

Therapeutic areas where superdisintegrants are used have been segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, inflammatory diseases, hematological diseases, and cardiovascular diseases. Among these segments, the gastrointestinal diseases segment is at the forefront of market growth due to the demand for fast acting medicine for these types of diseases. Meanwhile, the oncology segment is growing rapidly and is expected to display the highest CAGR over the forecast period.

Regional Analysis

Led by the U.S, the Americas have captured the largest share of the global superdisintegrants market. The presence of a developed healthcare sector as well as several important market players that have and continue to influence growth and contribute to the sizeable share that this regional market possesses. The region also has a high demand for drugs for many chronic diseases where superdisintegrants are required due to the prevalence of such diseases.

The Asia Pacific superdisintegrants market is likely to grow at the highest pace due to the concentration of rapidly emerging markets in the region. China, Japan, India, and several other country-level markets have a high demand for drugs for chronic diseases. The APAC regional market has several avenues for growth that are expected to open up in the coming years. The regions rapidly growing healthcare sector and the presence of a number of contract manufacturing organizations for pharmaceuticals is likely to have a positive impact on the market.

Browse More Report Details @ https://www.marketresearchfuture.com/reports/superdisintegrants-market-6663

Global Healthcare Asset Management Market Production, Capacity, Revenue, Price, Gross Margin Analysis And Forecast 2020-2023

 Healthcare Asset Management Market Overview

Healthcare asset management uses technologies such as Radiofrequency Identification (RFID) and plays a significant role in making efficient use of medical equipment, maintaining inventories, and minimizing human error. The hospital asset management system helps monitor and secure hospital facilities and uses automated software systems to track the environment on the hospital campus.

As per Market Research Future (MRFR) analysis, the healthcare asset management market is projected to grow at a CAGR of 18.2% from 2018 to 2023 (forecast period). The report on healthcare asset management is a comprehensive analysis and overview of drivers, restraints, opportunities, market trends, market size, forecasts, and developments in the healthcare asset management market. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6335

Healthcare Asset Management Market Dynamics

The increasing concern for patient safety, the need to make available resources more effective, and the adoption of advanced technology in the healthcare sector is expected to drive the healthcare asset management market growth. In addition, increasing investment in R&D and strategies adopted by major players such as the production of new products are contributing to market growth. For example, in August 2018, the latest version of Enterprise Asset Management (EAM) software was announced by Infor Inc., which is a major player in the healthcare asset management market.

Increasing concerns about patient safety, system accuracy problems, high deployment costs for healthcare asset management devices, and poor implementation due to organizational and infrastructure issues can impede market growth during the assessment period.

Healthcare Asset Management Market Key Players

Some of the key players in the healthcare asset management market are 

• cenTrak
• Airista Flow
• GE Healthcare
• IBM Corporation
• Infor Inc.
• Tyco Security Products.
• Intelligent InSites
• Motorola Solutions Inc.
• Radianse
• JADAK (a Novanta Company)
• Siemens Healthineers
• Sonitor Technologies
• Stanley Black & Decker Inc.
• Ekahau Inc.

Healthcare Asset Management Market Segmentation

The healthcare asset management market has been segmented on the basis of product, application, end-user, and region.

Based on the product, the market has been categorized as Real-Time Location Systems (RTLS), Radio Frequency Identification (RFID) devices and Ultrasound & Infrared Tags. The real-time location systems (RTLS) section was further divided into hardware, software, and services. The hardware section was further divided into tags/badges, and readers/interrogators.

Radio frequency identification (RFID) systems have been categorized as hardware, software, and services. The hardware section was divided into tags, readers/interrogators, and accessories. Sub-segment tags have been segmented into passive tags, and active tags. The passive tag section was slit into high-frequency (HF) tags, ultra-high-frequency (UHF) tags, and low-frequency (LF) tags. In addition, the application category has been sub-segmented in hospital asset management and pharmaceutical asset management. The hospital asset management section covers equipment monitoring and management, patient management, temperature and humidity monitoring, personnel management and prevention of diseases, and compliance with hand hygiene. The section of pharmaceutical asset management covers anti-counterfeiting drugs and supply chain management.

Based on end-user, the market has been segmented into Hospital/Clinic, Laboratories, Pharmaceutical companies, and Biotechnology.

Healthcare Asset Management Market Regional Analysis

Based on the region, the healthcare asset management market has been segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas are expected to dominate the healthcare asset management market due to the introduction of technologically advanced technologies, rising demand for innovative technology to combat counterfeit drugs and the existence of a well-established healthcare system, and the presence of a large network of health service providers. According to the American Hospital Association, there were 5,534 registered hospitals in the US in 2016, about 2,000 hospitals were in rural areas and more than 3,000 hospitals were located in urban areas.

The second-largest market for controlling healthcare assets is projected to be the European market. Business growth in this area can be attributed to government funding and support for the healthcare sector, combined with increased research and development. In addition, growing cases of product counterfeiting are responsible for increasing demand for healthcare asset management services and are therefore contributing to the growth of the market in the region. According to the European Intellectual Property Office, counterfeit drugs are a major concern in the healthcare sector. Revenue of USD 11,5 billion is lost annually as a result of counterfeit drugs and 10% of all globally supplied medicines are forged.

The Asia Pacific is projected to be the fastest-growing healthcare asset management market in the forecast period due to rising demand for easy-to-use asset management tools, rising digitalization in the region, and investment in healthcare and development by market players in the region.

The market in the Middle East and Africa is projected to account for the lowest share of the healthcare asset management market due to the underdeveloped healthcare system, inadequate medical services, and lack of professional expertise. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-asset-management-market-6335

About Market Research Future:

Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Sleeping Bruxism Treatment Market Overview By Trends, Industry Top Manufactures, Size, Industry Growth Analysis & Forecast Till 2023

 The latest report by Market Research Future (MRFR) affirms that the global sleeping bruxism treatment market is set to accrue USD 638.22 million at 6.7% CAGR during the forecast period (2018–2023). This growth can be put down to growing prevalence of dental diseases and consequently growing dental procedures coupled with growing funding and healthcare insurance coverage across the globe. Moreover, changing lifestyle, elevating demand for affordable healthcare delivery systems, rapid health insurance penetration, mergers and acquisitions to reach untapped markets, and government initiatives trigger the global market growth. Also, aging population and stressful lives led by a large population have an influence on the market.

 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5422

 

However, restraining factor such as expensive treatment may hinder the market growth to some level. On the flip side, several types of research and tests are being conducted to enhance treatment for sleep bruxism. Various methods such as drug therapy, behavioral therapy, custom dental and mouth guards are being developed to find out the most effective treatment procedure for sleeping bruxism. These researches help upgrade the treatment procedures, thus leading to market growth.

 

One of the most popular trends creating waves in sleeping bruxism treatment market is treating patient with behavior therapy. It involves the patient practicing proper jaw and mouth positions. The patient can also rest the tongue up with teeth apart and closed lips, which will counteract grinding.

 

Global Market for sleeping bruxism treatment – Segmental Analysis

 

MRFR’s report states that the sleeping bruxism treatment market is segmented on the basis of type, diagnosis, treatment type, cause, patient type, and end-user.

 

By type, the market is segmented into primary bruxism and secondary bruxism. The secondary bruxism segment accounted for the largest market share in 2017. Increasing sleep disorders, growing consumption of medicines which lead to dental side effects, and changing lifestyle due to stress can fuel the growth of the secondary bruxism segment.

 

By treatment, the market is segmented on the basis of dental approaches and medication. The dental approaches segment is divided into mouth guard and NTI-tss device. The medication segment is sub-segmented on the basis of muscle relaxants, Botox injections, and anti-anxiety drugs.

 

By cause, the global sleeping bruxism treatment market is segmented on the basis of obstructive sleep apnea, sleep paralysis, gastroesophageal reflux disease (GERD), malocclusion, and others. Among these, the obstructive sleep apnea segment is estimated to be worth USD 233.20 million by 2023, growing at a CAGR of 7.0% during the forecast period.

 

Pediatric and adult are two major segments under patient type. The pediatric segment held the largest market share in 2017. Prevalence of hyperactivity among children, growing anger issues, increasing pain from earache and teething, and even growing stress has fueled the growth of pediatric segment.

 

The end-users in the global sleeping bruxism treatment market are hospitals, dental clinics, and others. The end-users in the market are growing rapidly and will continue to grow at the same pace throughout the forecast period. The number of dental clinics has increased owing to growing awareness among patients regarding bruxism, government funding, and increasing number of dentists opening up standalone clinics.

 

Regional Outlook

 

The Americas market accounted for 39.1% share in 2017 in the sleeping bruxism treatment market. Factors such as rising stress and anxiety among the population have led to this market growth. Rising government funding and growing healthcare insurance coverage also contribute to the market’s expansion in the region.

 

Europe is the second largest market owing to growing cases of sleeping bruxism. High economy, growing dental awareness, growing number of dental clinics and healthcare infrastructure aid in market growth in the region. A large number of people also suffer from sleep disorders, snoring and irregular breathing which gives rise to sleeping bruxism, driving the market progress in the area.

 

On the other hand, Asia Pacific will observe steady growth due to rapid adoption of sophisticated healthcare technology, rapid economic growth, massive population size, and rise in investments in the healthcare sector. The pediatric population is growing tremendously which also shapes the market size positively. Furthermore, elevating awareness in terms of sleep bruxism and rapidly growing dental industry in countries such as China, India, Japan, and South Korea can spur overall market demand.

 

The Middle East & Africa market will experience sluggish growth as there is less exposure to the healthcare services along with lack of awareness about sleeping bruxism.

 

Global market for sleeping bruxism treatment– Competitive Dashboard

 

The key players competing in the market are S4S Dental Laboratory, Ipsen Biopharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Ivoclar Vivadent AG, Randmark and Dental Products LLC.

 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/sleeping-bruxism-treatment-market-5422